
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Catalent has broadened the scope of its OptiForm® Solution Suite platform to provide an efficient and seamless path from late-stage discovery to phase I clinical trials.
Catalent has broadened the scope of its OptiForm® Solution Suite platform to provide an efficient and seamless path from late-stage discovery to phase I clinical trials.
The new service includes more comprehensive candidate screening tools, ADME considerations and in silico DMPK modeling, as well as additional bioavailability enhancing tools, to provide materials for cGLP toxicological studies, and on to first-in-human studies.
14 Schoolhouse Rd, Somerset, NJ 08873
tel. +1.888.SOLUTION (765.8846)
AAPS Booth #3016






